Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Doctoral student Miranda Wood explores the flaws of the clinical psychology admissions process and the challenges prospective ...

A new weapon in the battle against malaria is emerging, and this time not from a laboratory, but rather driven by machine ...

Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply ...

Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...

With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving ...

Given the success of the Research Topic "Advancing Cancer Imaging Technologies: Bridging the Gap from Research to Clinical Practice", we are pleased to ...

Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...

The patient was a 73-year-old man with progressively disabling right hip pain for 2.5 years. The patient had failed ...

FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...

Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...